We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+11.71%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$7.51B
AUM Growth
+$668M
Cap. Flow
+$14M
Cap. Flow %
0.19%
Top 10 Hldgs %
34.2%
Holding
1,319
New
77
Increased
462
Reduced
700
Closed
61

Top Sells

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$9.39M
2
KO icon
Coca-Cola
KO
+$9.33M
3
UPS icon
United Parcel Service
UPS
+$8.35M
4
IBM icon
IBM
IBM
+$7.74M
5
UNP icon
Union Pacific
UNP
+$6.94M

Sector Composition

Rank Sector Weight
1 Technology 33.15%
2 Consumer Discretionary 12.56%
3 Healthcare 12.54%
4 Financials 10.24%
5 Communication Services 8.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LGF.B
1176
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
$133K ﹤0.01%
+15,887
New +$156K
RWT
1177
Redwood Trust
RWT
$582M
$131K ﹤0.01%
+20,540
New +$128K
MRVI icon
1178
Maravai LifeSciences
MRVI
$1.25B
$131K ﹤0.01%
10,524
-5,009
-32% -$67.6K
OPEN icon
1179
Opendoor
OPEN
$3.28B
$129K ﹤0.01%
33,217
+4,215
+15% +$9.15K
AEO icon
1180
American Eagle Outfitters
AEO
$2.8B
$128K ﹤0.01%
+10,808
New +$135K
DNA icon
1181
Ginkgo Bioworks
DNA
$489M
$127K ﹤0.01%
1,714
+607
+55% +$35.9K
DEI icon
1182
Douglas Emmett
DEI
$1.99B
$127K ﹤0.01%
10,066
-13,042
-56% -$158K
SHO icon
1183
Sunstone Hotel Investors
SHO
$2.08B
$125K ﹤0.01%
12,354
VNDA icon
1184
Vanda Pharmaceuticals
VNDA
$329M
$117K ﹤0.01%
+17,819
New +$114K
MDXG icon
1185
MiMedx Group
MDXG
$657M
$112K ﹤0.01%
+17,001
New +$86.7K
SIRI icon
1186
SiriusXM
SIRI
$9.61B
$112K ﹤0.01%
2,470
-6
-0.2% -$227
PAGS icon
1187
PagSeguro Digital
PAGS
$2.46B
$109K ﹤0.01%
+11,577
New +$117K
LAZR
1188
DELISTED
Luminar Technologies
LAZR
$109K ﹤0.01%
1,056
+97
+10% +$9.16K
NEX
1189
DELISTED
NexTier Oilfield Solutions Inc.
NEX
$101K ﹤0.01%
11,260
+1,210
+12% +$9.98K
MIR icon
1190
Mirion Technologies
MIR
$3.61B
$99.7K ﹤0.01%
+11,798
New +$95.7K
BORR
1191
Borr Drilling
BORR
$1.4B
$99.5K ﹤0.01%
13,218
+1,669
+14% +$12K
DRH icon
1192
Diamondrock Hospitality Co
DRH
$2.6B
$99.5K ﹤0.01%
12,418
+170
+1% +$1.38K
RKLB icon
1193
Rocket Lab Corp
RKLB
$43.2B
$98.4K ﹤0.01%
16,400
+4,086
+33% +$18.8K
RKT icon
1194
Rocket Companies
RKT
$40.3B
$96.6K ﹤0.01%
10,780
+194
+2% +$1.69K
LESL icon
1195
Leslie's
LESL
$4.99M
$96.3K ﹤0.01%
513
-536
-51% -$111K
HBI
1196
DELISTED
Hanesbrands
HBI
$95.3K ﹤0.01%
20,998
+8,721
+71% +$39.9K
ADT icon
1197
ADT
ADT
$5.45B
$94.9K ﹤0.01%
+15,730
New +$98.5K
GERN icon
1198
Geron
GERN
$983M
$94.2K ﹤0.01%
29,332
+5,294
+22% +$15.1K
VISN
1199
Vistance Networks Inc
VISN
$2.68B
$94.1K ﹤0.01%
16,712
+4,699
+39% +$22.5K
HLMN icon
1200
Hillman Solutions
HLMN
$1.53B
$91.5K ﹤0.01%
+10,154
New +$84.6K

Similar funds

Xponance's Q2 2023 Portfolio in Review

As of Q2 2023, Xponance held 1,319 positions worth $7.51B, up 9.8% from $6.84B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Xponance's Q2 2023 filing shows 77 new, 462 increased, 700 reduced and 61 closed positions. Its largest new stake was Coupang: 152,372 shares worth $2.65M. The largest sale was Procter & Gamble, an estimated $9.39M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2023 buy was Coupang: 152,372 shares worth $2.65M.
  • Xponance added most to Meta Platforms (Facebook) in Q2 2023, an estimated $45.1M increase.
  • Xponance's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $9.39M.
  • Xponance fully exited iShares Core MSCI International Developed Markets ETF in Q2 2023, selling an estimated $681K.
  • Xponance's ten largest holdings make up 34% of its $7.51B portfolio in Q2 2023.
  • Xponance opened 77 new positions and closed 61 in Q2 2023.
  • Xponance's portfolio value rose 9.8% quarter-over-quarter to $7.51B.

Based on Xponance's 13F filing for Q2 2023, filed 14 Jul 2023.